Современная онкология (Sep 2016)
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
- L V Bolotina,
- L V Manziuk,
- V A Gorbunova,
- E I Kovalenko,
- G Z Mukhametshina,
- A I Khasanova,
- L Yu Vladimirova,
- I S Mitashok,
- E P Prokofyeva,
- I V Evstigneeva,
- I I Andreyashkina,
- N A Abramova,
- I L Popova,
- E V Karabina,
- A A Teterich,
- E A Gaysina,
- V A Chubenko,
- S V Limareva,
- N M Tikhanovskaya,
- A E Storozhakova,
- N Yu Samaneva,
- Ya V Svetitskaya,
- T A Snezhko,
- E A Kalabanova
Affiliations
- L V Bolotina
- P.A.Herzen Moscow Research Institute of Oncology of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
- L V Manziuk
- N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
- V A Gorbunova
- N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
- E I Kovalenko
- N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
- G Z Mukhametshina
- Tatarstan Regional Clinical Cancer Center
- A I Khasanova
- Tatarstan Regional Clinical Cancer Center
- L Yu Vladimirova
- Rostov Research Institute of Oncology
- I S Mitashok
- Rostov Research Institute of Oncology
- E P Prokofyeva
- SFHI Penza Regional Oncology Dispensary
- I V Evstigneeva
- Tver Regional Clinical Oncology Dispensary
- I I Andreyashkina
- Saratov Regional Oncology Dispensary No.2
- N A Abramova
- Rostov Research Institute of Oncology
- I L Popova
- Rostov Research Institute of Oncology
- E V Karabina
- Tula Regional Oncology Dispensary
- A A Teterich
- Belgorod Regional Oncology Dispensary
- E A Gaysina
- State Autonomous institution of public Health «Multidisciplinary Clinical Medical Center «Medical Town»
- V A Chubenko
- SFHI St. Petersburg Clinical Research and Practical Center of Specialized Types of Medical Care (Oncologic)
- S V Limareva
- N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
- N M Tikhanovskaya
- Rostov Research Institute of Oncology
- A E Storozhakova
- Rostov Research Institute of Oncology
- N Yu Samaneva
- Rostov Research Institute of Oncology
- Ya V Svetitskaya
- Rostov Research Institute of Oncology
- T A Snezhko
- Rostov Research Institute of Oncology
- E A Kalabanova
- Rostov Research Institute of Oncology
- Journal volume & issue
-
Vol. 18,
no. 3
pp. 27 – 32
Abstract
The article shows the experience of eribulin application in actual clinical practice in Oncology institutions of the Russian Federation concerning metastatic breast cancer. We have analyzed the efficacy of the drug in case of different subtypes of the tumor and have chosen patients, depending on the location of metastases and with proven maximum efficacy of eribulin. We have shown the side reactions and the possibility of application of eribulin in combination with other antineoplastic agents.
